摘要
The combination of immune checkpoint blockade (ICB) and chemotherapy has shown significant potential in the clinical treatment of various cancers. However, circulating regeneration of PD-L1 within tumor cells greatly limits the efficiency of chemo-immunotherapy and consequent patient response rates. Herein, we report the synthesis of a nanoparticle-based PD-L1 inhibitor (FRS) with a rational design for effective endogenous PD-L1 suppression. The nanoinhibitor is achieved through self-assembly of fluoroalkylated competitive peptides that target PD-L1 palmitoylation. The FRS nanoparticles provide efficient protection and delivery of functional peptides to the cytoplasm of tumors, showing greater inhibition of PD-L1 than nonfluorinated peptidic inhibitors. Moreover, we demonstrate that FRS synergizes with chemotherapeutic doxorubicin (DOX) to boost the antitumor activities via simultaneous reduction of PD-L1 abundance and induction of immunogenic cell death in murine colon tumor models. The nano strategy of PD-L1 regulation present in this study is expected to advance the development of ICB inhibitors and overcome the limitations of conventional ICB-assisted chemo-immunotherapy.
学科与关键词
- Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapyYin, Shuangneng; Chen, Zhaojun; Chen, Dugang*; Yan, Dan*2023, 13(5): 1520-1544.被引 16
- Liposome-coated CaO2 nanoblockers for enhanced checkpoint blockade therapy by inhibiting PD-L1 de novo biosynthesisChe, Ruijun; Han, Dandan; Wang, Fei; Liu, Huifang; Fan, Miao; Yan, Hongyu; Xiao, Tingshan; Wang, Zhaoshuo; Zhou, Xiaohan; Wang, Xueyi; Zhang, Kaihan; Ou, Caiwen; Zhang, Jinchao*; Li, Zhenhua*Nano Research, 2023, 16(5): 7227-7236.被引 1
- Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response (Aug, 10.1039/d1nr03288g, 2021)Yu, Jie; He, Xidong; Wang, Zigui; Wang, Yupeng; Liu, Sha; Xie, Zhigang; Li, Xiaoyuan*; Huang, Yubin*Nanoscale, 2021, 13(32): 13907-13907.
